FDA Vaccine Chief's Controversial Departure Shakes Agency
Dr. Vinay Prasad, the FDA's vaccine chief, steps down amid controversy after brief tenure. Prasad faced criticism for halting shipments of a gene therapy after patient deaths, attracting ire from pro-Trump activists. He leaves to focus on family, with Dr. George Tidmarsh succeeding in an acting role.

- Country:
- United States
The Food and Drug Administration's top vaccine official, Dr. Vinay Prasad, has exited the agency amidst a brief and tumultuous tenure that stirred discontent among biotech stakeholders and President Trump's conservative allies.
According to the Department of Health and Human Services, Prasad is stepping down to spend more time with his family, but insiders report he was forced out following controversies, including an oversight decision on gene therapy shipments.
Prasad's departure highlights friction with Trump's base over his scepticism towards accelerated drug approvals, an approach clashing with the administration's push for wider access to experimental treatments.
(With inputs from agencies.)
ALSO READ
Controversy Surrounds Detention of South Korea's Ousted Leader
U.S. Deportation Flight to Eswatini Sparks Controversy
Tara Moore's Four-Year Ban Upheld: The Nandrolone Controversy
Supreme Court to Hear Plea on NEET-UG 2025 Retest Amid Power Outage Controversy
Controversy Erupts as Karnataka MLA Booked in Murder Case